Lipocalin 2 mediates appetite suppression during pancreatic cancer cachexia
Sign Up to like & getrecommendations! Published in 2021 at "Nature Communications"
DOI: 10.1038/s41467-021-22361-3
Abstract: Lipocalin 2 (LCN2) was recently identified as an endogenous ligand of the type 4 melanocortin receptor (MC4R), a critical regulator of appetite. However, it remains unknown if this molecule influences appetite during cancer cachexia, a… read more here.
Keywords: lcn2; appetite suppression; pancreatic cancer; cancer cachexia ... See more keywords